Latest Regulatory Approval News

AUB Group Limited has announced the acquisition of a 95.9% stake in UK-based PIHL Holdings Limited (Prestige) for AUD 432 million, significantly expanding its UK retail insurance broking footprint. To fund this strategic move, AUB is launching a fully underwritten AUD 400 million institutional placement alongside a share purchase plan.

Toubani Resources is poised to begin construction on its Kobada Gold Project in Mali after securing key environmental approvals and a substantial financing package. The company is advancing rapidly towards becoming a major gold producer in Africa.

Energy Transition Minerals Ltd (ETM) reported key progress in its December 2025 quarter, including legal developments for its Greenland rare earth project, advancing a strategic mine acquisition in Spain, and moves toward a US Nasdaq listing.

EMVision Medical Devices reports strong progress in its emu™ Brain Scanner clinical trials, expanding recruitment across seven leading stroke hospitals and introducing new software features to enhance scan quality.

Viking Mines has completed a cutting-edge drone survey at its Linka Tungsten Project, integrating 1970s data with modern technology to fast-track exploration and permitting.

Energy Resources of Australia (ERA) reports ongoing legal challenges over the Jabiluka Mineral Lease and a compulsory acquisition court hearing, alongside delays in key rehabilitation works at the Ranger Project Area.

Orezone Gold Corporation has announced its acquisition of the Casa Berardi gold mine in Quebec, Canada, marking a strategic expansion into a Tier 1 mining jurisdiction and significantly boosting its production profile.

Orezone Gold Corporation has announced a transformative acquisition of the Casa Berardi gold mine in Quebec, marking its entry into a Tier 1 mining jurisdiction and significantly boosting production and cash flow.

Actinogen Medical has locked in a $4.3 million tranche of non-dilutive funding to support its pivotal Alzheimer’s disease trial, reinforcing its financial position as it nears critical interim and final results.

Singular Health Group has advanced its U.S. commercial footprint with the deployment of 500 new licences under its PNS contract and secured FDA clearance for its cloud-based 3DICOM MD® platform, positioning the company for significant growth.

Mont Royal Resources has signed a non-binding Memorandum of Understanding with the Saguenay Port Authority to explore locating a hydrometallurgical facility for its Ashram Rare Earths Project in Québec, leveraging the port’s strategic logistics and industrial infrastructure.

Island Pharmaceuticals has secured key regulatory milestones for its antiviral Galidesivir, including FDA confirmation of the Animal Rule pathway and Priority Review Voucher eligibility, while strengthening US biodefense ties and expanding patent protection.